Interacting Drugs |
Tolterodine vs VinBLAStine |
Security Level |
 |
Mechanism |
VinBLAStine: May increase the serum concentration of Tolterodine. |
Management |
Reduce tolterodine dose to 1 mg twice daily (regular release formulation) or 2 mg daily (extended release formulation) (adult doses) and monitor for increased levels/effects of tolterodine with initiation of vinblastine therapy. |
Tolterodine vs VinBLAStine
Post Review about Tolterodine vs VinBLAStine Click here to cancel reply.
Other Interactions of Tolterodine
Other Interactions of VinBLAStine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.